{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicnkhgofb2uko33j4bitzcdn2mwhhbi37bqfnignu4hi34rud2hgm",
    "uri": "at://did:plc:yvpkwzscqadwgkjjwcpe36s2/app.bsky.feed.post/3midpbe33f7y2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihehyadi7mzkskzt6iuarfth4cvnffuelednernqovqzquwgnjkqa"
    },
    "mimeType": "image/png",
    "size": 25110
  },
  "path": "/2026/03/31/lupin-receives-tentative-usfda-approval-for-generic-sugammadex-injection/",
  "publishedAt": "2026-03-31T07:37:18.000Z",
  "site": "https://thechenabtimes.com",
  "tags": [
    "Americas",
    "Generic Drugs",
    "Lupin Limited",
    "Muscle Relaxants",
    "pharmaceuticals",
    "Sugammadex Injection",
    "surgery",
    "usfda"
  ],
  "textContent": "Pharma major Lupin Ltd has received tentative approval from the USFDA for its generic Sugammadex injection, used to reverse muscle relaxants post-surgery. The approval is for specific strengths in single-dose vials and finds the generic bioequivalent to Merck's Bridion.",
  "title": "Lupin receives tentative USFDA approval for generic Sugammadex injection"
}